CD14 and lymphoma: One of the findings in the present study was that the absolute number of total CD14+ monocytes was increased in this cohort, which is different to our previous publication in which we reported that there was no difference in the percentage of monocytes between lymphoma patients and controls.14 This discrepancy may be due to differing results when the absolute monocyte count and monocyte percentage are used as readouts.